WAT
WATERS CORP /DE/
NYSE · Healthcare · Medical - Diagnostics & Research · US
$480.07
+0.67%Forward multiples
Based on analyst estimates
- P/E forward
- 29.99x
- P/E 2026E
- 33.00x
- P/E 2027E
- 29.14x
- P/E 2028E
- 26.04x
- P/S forward
- 6.76x
Trailing multiples
Trailing twelve months
- P/E TTM
- 119.42x
- PEG TTM
- 0.40x
- Price / book
- 3.10x
- Price / sales
- 10.16x
- Price / cash flow
- 85.78x
Enterprise value
- Enterprise value
- $51.9B
- EV / sales
- 11.17x
- EV / EBITDA
- 54.57x
- EV / EBIT
- 140.34x
- Market cap
- $47.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jul 1, 2026